NCT04725032
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 65 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must be scheduled to surgically remove tumors near the part of the brain known as the sella turcica (e.g. sellar or parasellar tumors)
Exclusions: 
https://ClinicalTrials.gov/show/NCT04725032